Viloxazine (Qelbree): A Faster Strattera?

On April 2, 2021, viloxazine, brand name Qelbree, received FDA approval for the treatment of ADHD in children and adolescents ages 6-17 years old. The latest issue of The Carlat Child Psychiatry Report includes a News of Note covering this newly approved medication for ADHD. In this podcast, we discuss the advantages and disadvantages of viloxazine for children and adolescents with ADHD.

https://www.thecarlatreport.com/podcast/viloxazine-qelbree-a-faster-strattera-2/

Author

Joshua Feder, M.D. Dr. Feder's Blog

You Might Also Enjoy...

Hidden Dangers: The Fentanyl Crisis and Teen Overdose Prevention

The Fentanyl overdose crisis is now one of the leading causes of death among adolescents, and it is happening in every corner of the country. In this podcast Dr Feder talks about the state of the crisis and the steps we can take to save lives.

From Fentanyl to Nicotine: The Carlat Child Psychiatry Winter 2025 Substance Use Audio Version

In this audio recording of the Winter CCPR we cover the overdose crisis, nicotine addiction, and what level of care might needed for youth with substance use problems, along with a variety of other practical clinical and research updates - enjoy!

Social Isolation in Teens: Audio by Dr Feder of the Carlat Child Psychiatry Report Summer 2024

Do you really want to hear me talking through the entire issue from summer 2024, Addressing Social Isolation in Teens? Clocking at just over an hour (you might want to skip the multiple choice questions at the end). Tell me what you think! Dr Feder

Navigating the Digital Generation: Social Media & Mental Health

In today's podcast, we explore the connection between social media, mental health, and today's youth. We cover

Comprehensive Assessment and Treatment of ADHD: A Carlat Webinar with Dr Josh Feder

In this webinar I help you Identify co-occurring conditions associated with ADHD., describe key components of a comprehensive ADHD assessment, and discuss effective strategies for environmental, psychological, and biological management of ADHD symptoms..

Landmark article on autism care

A new landmark article on autism care was released on December 24, 2024. This article, by Dr. Diane Cullinane and a team including Dr Feder, is the defining foundation for the field of Developmental Relationship Based approaches to autism . Read it free!